136 related articles for article (PubMed ID: 23186804)
1. Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7.
Kakisu E; Abraham AG; Farinati CT; Ibarra C; De Antoni GL
J Dairy Res; 2013 Feb; 80(1):64-71. PubMed ID: 23186804
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of Lactobacillus acidophilus lysates on the cytotoxic activity of shiga-like toxin 2 produced from Escherichia coli O157:H7.
Kim Y; Han KS; Imm JY; Oh S; You S; Park S; Kim SH
Lett Appl Microbiol; 2006 Nov; 43(5):502-7. PubMed ID: 17032223
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical, microbiological and sensory profiles of fermented milk containing probiotic strains isolated from kefir.
Kakisu E; Irigoyen A; Torre P; De Antoni GL; Abraham AG
J Dairy Res; 2011 Nov; 78(4):456-63. PubMed ID: 22004606
[TBL] [Abstract][Full Text] [Related]
4. Kefir-isolated Lactococcus lactis subsp. lactis inhibits the cytotoxic effect of Clostridium difficile in vitro.
Bolla PA; Carasi P; Serradell Mde L; De Antoni GL
J Dairy Res; 2013 Feb; 80(1):96-102. PubMed ID: 23217732
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
6. Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects Vero cells.
Percivalle E; Monzillo V; Pauletto A; Marone P; Imberti R
New Microbiol; 2016 Apr; 39(2):119-23. PubMed ID: 27196550
[TBL] [Abstract][Full Text] [Related]
7. Relative cytotoxicity of Escherichia coli O157:H7 isolates from beef cattle and humans.
Lefebvre B; Diarra MS; Vincent C; Moisan H; Malouin F
Foodborne Pathog Dis; 2009 Apr; 6(3):357-64. PubMed ID: 19278343
[TBL] [Abstract][Full Text] [Related]
8. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
Sheng L; Rasco B; Zhu MJ
Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
[TBL] [Abstract][Full Text] [Related]
9. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
Liu J; Sun Y; Feng SZ
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
11. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
12. Intestinal mucosa adherence and cytotoxicity of a sorbitol-fermenting, Shiga-toxin-negative Escherichia coli O157:NM isolate with an atypical type III secretion system.
Lefebvre B; Diarra MS; Fairbrother JM; Nadeau E; Dubois M; Malouin F
Foodborne Pathog Dis; 2010 Aug; 7(8):985-90. PubMed ID: 20482230
[TBL] [Abstract][Full Text] [Related]
13. Probiotic inhibits the cytopathic effect induced by Escherichia coli O157:H7 in Vero cell line model.
Tahamtan Y; Kargar M; Namdar N; Rahimian A; Hayati M; Namavari MM
Lett Appl Microbiol; 2011 May; 52(5):527-31. PubMed ID: 21355874
[TBL] [Abstract][Full Text] [Related]
14. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
[TBL] [Abstract][Full Text] [Related]
15. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
[TBL] [Abstract][Full Text] [Related]
16. Isogenic strain of Escherichia coli O157:H7 that has lost both Shiga toxin 1 and 2 genes.
Feng P; Dey M; Abe A; Takeda T
Clin Diagn Lab Immunol; 2001 Jul; 8(4):711-7. PubMed ID: 11427416
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Escherichia coli O157:H7 and E. coli virulence factors in US bulk tank milk as determined by polymerase chain reaction.
Karns JS; Van Kessel JS; McClusky BJ; Perdue ML
J Dairy Sci; 2007 Jul; 90(7):3212-9. PubMed ID: 17582104
[TBL] [Abstract][Full Text] [Related]
19. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
Kongmuang U
Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
[TBL] [Abstract][Full Text] [Related]
20. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.
Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH
Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
